Cowen Healthcare Royalty Partners
home
About Cowen Royalty
Cowen Royalty Approach
Cowen Royalty Team
Cowen Royalty Portfolio
Cowen Royalty News
Contact Cowen Royalty
News
Press Releases
In the News
Presentations and Publications
Press Releases
Nov 06 2009
Surviving Healthcare Reform: How Biopharma Companies Can Come Out on Top
Sep 17 2009
Cowen Healthcare Royalty Partners Establishes Strategic Advisory Board
Mar 18 2009
Dyax Amends Loan Agreement with Cowen Healthcare Royalty Partners for an Additional $15 Million
Nov 12 2008
Æterna Zentaris Agrees to Sell Cetrotide® Royalty Stream for $52.5MM to Cowen Healthcare Royalty Partners
Aug 26 2008
Indevus Announces Private Placement of $105 Million of Non-Recourse Notes Notes Secured by Royalties on U.S. Sales of SANCTURA(R) and SANCTURA XR™
Aug 21 2008
LifeCycle Pharma Sells FenoglideTM Royalty Stream to Cowen Healthcare Royalty Partners
Aug 06 2008
Dyax Enters into $50MM Agreement with Cowen Healthcare Royalty Partners
Jul 21 2008
Cowen Healthcare Royalty Partners and Cowen Group, Inc. Announce Closing of Fund
Jun 03 2008
Vertex Pharmaceuticals Sells HIV Product Royalty Stream for $160 Million
Apr 23 2008
Supernus Pharmaceuticals Completes $75 Million Non-Recourse Note Offering Secured by Oracea® and Sanctura® XR Royalties
Feb 19 2008
Cowen Group, Inc. and Cowen Healthcare Royalty Partners Announce Expansion of Team